Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVOFLOXACIN vs LEVOKETOCONAZOLE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LEVOFLOXACIN vs LEVOKETOCONAZOLE: Safety Overview

Metric LEVOFLOXACIN LEVOKETOCONAZOLE
Total FAERS Reports 40,403 309
Deaths Reported 2,747 8
Death Rate 6.8% 2.6%
Hospitalizations 13,832 99
Average Patient Age 59.4 yrs 54.8 yrs
% Female Patients 54.7% 86.3%
FDA Approval Date Apr 22, 2020 Dec 30, 2021
Manufacturer BPI LABS LLC Xeris Pharmaceuticals, Inc.
Route OPHTHALMIC ORAL
Marketing Status Discontinued Prescription